Advertisement
News
Advertisement

Genzyme ordered to pay $50M in patent dispute

Wed, 07/25/2012 - 12:00am
Mass High Tech: The Journal of New England Technology

Cambridge, Mass.-based Genzyme Corp., a subsidiary of French drug maker Sanofi (NYSE: SNY), has been ordered to pay $50 million to privately-held New Jersey-based biotechnology company Shelbyzyme LLC.

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading